| Primary |
| Actinic Keratosis |
32.2% |
| Skin Papilloma |
8.5% |
| Drug Use For Unknown Indication |
6.8% |
| Vaginal Dysplasia |
6.8% |
| Chemotherapy |
5.1% |
| Precancerous Skin Lesion |
5.1% |
| Skin Cancer |
5.1% |
| Hyperkeratosis |
3.4% |
| Hypertension |
3.4% |
| Precancerous Cells Present |
3.4% |
| Product Used For Unknown Indication |
3.4% |
| Skin Lesion |
3.4% |
| Angiodysplasia |
1.7% |
| Basal Cell Carcinoma |
1.7% |
| Bowen's Disease |
1.7% |
| Cervicitis Human Papilloma Virus |
1.7% |
| Papilloma Viral Infection |
1.7% |
| Penile Wart |
1.7% |
| Skin Discolouration |
1.7% |
| Skin Disorder |
1.7% |
|
| Rash Generalised |
9.1% |
| Talipes |
9.1% |
| Blood Urine Present |
6.8% |
| Vomiting |
6.8% |
| Vulvovaginal Discomfort |
6.8% |
| Angioedema |
4.5% |
| Death |
4.5% |
| Facial Palsy |
4.5% |
| Hypertension |
4.5% |
| International Normalised Ratio Increased |
4.5% |
| Nausea |
4.5% |
| Pruritus |
4.5% |
| Skin Discolouration |
4.5% |
| Skin Exfoliation |
4.5% |
| Skin Lesion |
4.5% |
| Therapy Non-responder |
4.5% |
| Toxicity To Various Agents |
4.5% |
| Bedridden |
2.3% |
| Blood Creatine Phosphokinase Increased |
2.3% |
| Drug Administration Error |
2.3% |
|
| Secondary |
| Colorectal Cancer |
32.9% |
| Gastric Cancer |
10.9% |
| Colon Cancer Metastatic |
9.7% |
| Colon Cancer |
9.4% |
| Rectal Cancer |
7.3% |
| Premedication |
6.0% |
| Prophylaxis Of Nausea And Vomiting |
2.7% |
| Constipation |
2.4% |
| Metastatic Gastric Cancer |
2.4% |
| Oesophageal Adenocarcinoma Metastatic |
2.4% |
| Prophylaxis |
2.4% |
| Rectal Cancer Metastatic |
2.4% |
| Colorectal Cancer Metastatic |
1.5% |
| Product Used For Unknown Indication |
1.5% |
| Hyperuricaemia |
1.2% |
| Pain In Extremity |
1.2% |
| Pancreatic Carcinoma |
1.2% |
| Breast Cancer |
0.9% |
| Oesophageal Carcinoma |
0.9% |
| Anaemia |
0.6% |
|
| Diarrhoea |
18.2% |
| Dehydration |
9.1% |
| Pulmonary Embolism |
9.1% |
| Death |
6.1% |
| Hyperammonaemia |
6.1% |
| Interstitial Lung Disease |
6.1% |
| Shock Haemorrhagic |
6.1% |
| Anaemia |
3.0% |
| Arrhythmia |
3.0% |
| Blood Bilirubin Increased |
3.0% |
| Dermatitis Acneiform |
3.0% |
| Febrile Neutropenia |
3.0% |
| Gastritis |
3.0% |
| Leukopenia |
3.0% |
| Pancytopenia |
3.0% |
| Renal Failure |
3.0% |
| Renal Impairment |
3.0% |
| Respiratory Alkalosis |
3.0% |
| Sudden Death |
3.0% |
| White Blood Cell Count Decreased |
3.0% |
|
| Concomitant |
| Hiv Infection |
21.4% |
| Colorectal Cancer |
13.0% |
| Colon Cancer Metastatic |
10.5% |
| Large Intestine Carcinoma |
8.2% |
| Product Used For Unknown Indication |
8.0% |
| Hypertension |
5.5% |
| Colon Cancer |
4.4% |
| Breast Cancer Metastatic |
3.1% |
| Hormone Replacement Therapy |
3.1% |
| Breast Cancer |
2.9% |
| Rectal Cancer Metastatic |
2.9% |
| Prophylaxis |
2.7% |
| Depression |
2.3% |
| Drug Use For Unknown Indication |
1.9% |
| Hypersensitivity |
1.9% |
| Pain |
1.9% |
| Premedication |
1.7% |
| Rectosigmoid Cancer Metastatic |
1.7% |
| Arthritis |
1.5% |
| Gastrooesophageal Reflux Disease |
1.5% |
|
| Death |
9.4% |
| Mechanical Ileus |
8.3% |
| Squamous Cell Carcinoma |
7.3% |
| Colonic Fistula |
6.3% |
| Epistaxis |
6.3% |
| Ileal Perforation |
6.3% |
| Gamma-glutamyltransferase Increased |
5.2% |
| Hepatic Failure |
5.2% |
| Infusion Related Reaction |
5.2% |
| Abdominal Pain |
4.2% |
| Ileus Paralytic |
4.2% |
| Interstitial Lung Disease |
4.2% |
| Nausea |
4.2% |
| Squamous Cell Carcinoma Of Skin |
4.2% |
| Urticaria |
4.2% |
| Altered State Of Consciousness |
3.1% |
| Disease Progression |
3.1% |
| Organising Pneumonia |
3.1% |
| Palpitations |
3.1% |
| Renal Tubular Necrosis |
3.1% |
|
